Molecular and Cellular Mechanism in the course of Immunotherapy with a Phleum Pratense Oral Lyophilisate
Phase of Trial: Phase IV
Latest Information Update: 04 Feb 2017
At a glance
- Drugs Timothy grass pollen allergen extract (Grastek) (Primary)
- Indications Allergic rhinitis; Allergic rhinoconjunctivitis; Grass pollen hypersensitivity
- Focus Biomarker; Pharmacodynamics
- Sponsors ALK-Abello
- 04 Feb 2017 Last checked against ClinicalTrials.gov record.
- 05 Aug 2016 Status changed from active, no longer recruiting to completed.
- 23 Feb 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.